Recent advances in HIV pathogenesis  by unknown
16 Journal of Clinical Microbiology and Infection, Volume 3 Supplement 2 
A Global Survey Yeast Susceptibility to 
Fluconazole 
J.M. Torres-Rodriguez ’ , G. Quind6s ’. ’ Cmp de Recerca en 
Micologia Expm’mental I Clhica, lMLM. /Universifat Autbnoma de 
Barcelona, Spain, ’ e t .  Minobiology Far. Medicine, Euskadi University, 
Bilbaq Spain 
Fluconazole is currently the azole antifungal drug most used for the 
treatment of yeast mfections because of its high rate of efficacy, low 
toxicity and simplicity of a b t r a t i o n .  As a result of the wide use 
of fluconazole, particularly as prophylaxis and treatment of oropha- 
ryngeal candidosis in HN-infected patients, changes in the suscepti- 
blity of some strains of Candida albirans and the emergence of other 
species less susceptible in vitro such as Candid0 ktusk and Tomlopsis 
(Candida) glabratu have occurred. The significance of these effects on 
the course of the disease is controversial. 
Stukes of susceptibility to Flucon&ole have been pubhhed by 
many laboratories in several countries, most of them h m  the USA. 
In general terms the results seem to be similar but there are Wer- 
ences in methodology and procedure. 
In a multicentre survey of in vitro antifungal resistance in yeasts of 
medical importance isolated form Spanish patients, the susceptibility 
to fluconazole was 90.2%; only 4% of C. albiram strains were not 
susceptible. Most resistance was seen in C. glabrata and C. guillier- 
mondii. AU C. tropicalis were susceptible to fluconazole. Conclusions 
of thts study were that resistance to antifungals is very low in Spain 
and it is related to a few non-albicanc species. 
Glauser et al conducted a multicentre study in 23 Werent coun- 
tries with 2231 consecutively isolated Candida strains in whch a 
fluconazole difFusion assay was performed. The results of this study 
showed the 97.1% of C. albicans strains were susceptible to this an- 
tifungal. When other species of Candida were studied the suscepti- 
bility was lower (83.4%). The results of the difLsion test correlated 
with MICs (NCCLS proposals) for susceptible or intermediate saains 
when the zones of inhibition were 18-25 mm. 
These results suggested a low in vitro world-wide resistance of 
Candida albirnns to fluconazole and variable susceptibility depending 
on the other Candida species considered. 
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In a group of 14 HIV-infected persons, mean loss of telomere length 
in PBMC over 3 to 9 years was sigmficantly increased compared 
to mean loss of TRF length in 7 healthy contmls. Loss of telom- 
ere length in HIV infection was found exdusively in CD8+ T cells 
and not in CD4+ T cells. Loss of telomere length could not be 
explained by differential telomerase activity. This provides evidence 
that turnover in the course of HIV-1 infection can be increased con- 
siderably in CD8+ T cells, but not in CD4+ T cells. T ~ I S  implies 
that CD4+ T cell decline in HIV-1 infection might be caused by 
&bition of CD4+ T cell renewal. To further study T cell renewal 
capacity and kinetics we evaluated the repopulation of CD4+ and 
CD8+ T cell subsets and their functional improvement during the 
first 36 weeks of treatment with ritonavir, 3TC and zidovudine that 
induced a strong and persistent reduction of the plasma and lym- 
phoid viral load. A strikingly distinct kinetics for CD4+ CD45RO+ 
and RA+ cells was observed. CD45RO+ cell repopulation followed 
a biphasic pattern, with a steep increase in the first 5 weeks and a 
gradual slow increase the following months. In contrast, the naive 
CD62L+ cells over the follow up period showed a slow and gradual 
increase with a mean increase of 10’ cells per day. In addition, a sus- 
tained improvement of T cell function was seen in the patients. Our 
results demonstrate that immunereconstitution following anti-viral 
therapy may be slow and may not readily reach normal levels of 
immunocompetence. 
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Quantitative image analysis of sections of lymphatic tissues (LT) after 
in situ hybridization to reveal viral RNA, or immunohistochemisay 
to identlfy subsets of CD4+ T cells af50rd.s new opportunities to 
understand the pathogenesis of infection and response to treatment. 
I wiU describe the results of recent experiments on the response to 
combinations of antiretroviral therapy in LT that define the kinet- 
ics and magnitude of this response. I wiU also describe the rate of 
CD4+ T cell replacement that suggests a “Red Queen” mechanism 
of immune depletion in HIV-1 infection. 
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